• Manufacturing

BioIVT Launches GMP Grade Human AB Serum to Facilitate the Development and Manufacturing of Cell and Gene Therapies

This cell culture supplement can be used to manufacture both autologous and allogeneic cell therapies.

eXmoor Pharma secures contract to work with New Zealand Blood Service

eXmoor Pharma, experts in strategic and technical biomanufacturing, specialising in cell and gene therapy, has signed a deal to work with the New Zealand Blood Service (NZBS). Bristol-based eXmoor, which has worked in over 15 countries worldwide, will be providing NZBS with valuable Quality support as they build and establish a new site near Auckland.

CEO Update | 17 January 2022

The UK sector was out in virtual force at the annual JP Morgan Healthcare conference held virtually last week. It was great to see UK companies at the forefront of the global themes. I’m really looking forward to seeing many of you on 27 January as we gather in person to celebrate the achievements of the sector at the BIA Gala Dinner. I’m glad to confirm that Science Minister George Freeman MP will be our pre dinner keynote speaker.

Delivery of Cell and Gene Therapy Transformed

A new product developed between Bedford-based Life Science Group Ltd (LSG) and Coventry University has the potential to transform the delivery of cell and gene therapy and in the longer term make these cutting-edge, personalised treatments more accessible.

GHO Capital invests in RoslinCT, a leading cell therapy CDMO

RoslinCT, a leading Contract Development and Manufacturing Organization (CDMO) focused on advanced cell therapies, announces investment from Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in global healthcare.

New Cambridge office to support local biologics SMEs

We’ve opened a new office at the Cambridge Innovation Park to help SMEs realise their potential and drive economic prosperity in the region’s innovation ecosystem.

Cincinnati Children's teams with CTI on joint venture

Cincinnati Children's Hospital Medical Center and the research service provider CTI Clinical Trial & Consulting Services have agreed to form a company that will focus on providing cell and gene therapy manufacturing services to the biotechnology and pharmaceutical industries.

Guest blog: State of the UK cell and gene therapy industry in 2021

Despite the pandemic the cell and gene therapy industry in the UK has had another year of significant growth. The Cell and Gene Therapy Catapult has assessed the UK landscape in terms of investment, jobs and manufacturing capabilities and space. The organisation has published two 2021 reports, one focused on skills demand and one on GMP manufacturing.

CEO Update | 15 November 2021

Thank you to everyone who joined us at the Babraham Research Campus in Cambridge last week. It was great to meet BIA members, local start-ups and academics to talk about collaboration. We raised the question of whether more or better collaborations are needed, and ultimately found that success lies in finding a common goal and sharing the benefits of your product.

BioPharma Dynamics unveil brand new cleanroom facility to support the Life Sciences Industry

BioPharma Dynamics, a leading life sciences solution provider, proudly announce the opening of their new ISO Class 7 cleanroom facility located at new headquarters in Salford, Greater Manchester.